Pediatric T-cell acute lymphoblastic leukemia.

Area of Science:

• Pediatric Oncology
• Cancer Genetics
• Epigenetics

Background:

• Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy.
• T-cell ALL (T-ALL), a subtype of ALL, originates from immature thymocytes and accounts for 10-15% of cases.
• T-ALL pathogenesis involves a stepwise accumulation of genetic and epigenetic aberrations affecting critical cellular processes.

Purpose of the Study:

• To provide an overview of pediatric T-cell ALL.
• To emphasize the acquired genetic alterations driving T-ALL development.
• To highlight the need for integrating genetic and epigenetic data for clinical application.

Main Methods:

• Review of acquired genetic alterations in T-ALL.
• Analysis of epigenetic modifications including DNA methylation and non-coding RNAs.
• Examination of gene expression patterns and their clinical associations.

Main Results:

• T-ALL involves genetic alterations like translocations, deletions, and mutations in key regulatory genes.
• Epigenetic changes include hypermethylation of tumor suppressor genes, histone modifications, and aberrant miRNA/lncRNA expression.
• Massive parallel sequencing has identified numerous fusion genes and novel mutations in T-ALL.

Conclusions:

• Genetic and epigenetic aberrations disrupt normal thymocyte differentiation, proliferation, and apoptosis.
• Current genetic and gene expression patterns lack routine clinical implementation for treatment decisions.
• Integrating comprehensive genetic and epigenetic data is crucial for advancing T-ALL risk stratification and targeted therapeutic strategies.